Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.95 |
| ▸ | CA12 | O43570 | 5/20 | 0.95 |
| ▸ | CA1 | P00915 | 5/20 | 0.95 |
| ▸ | CA2 | P00918 | 5/20 | 0.95 |
| ▸ | CA7 | P43166 | 5/20 | 0.95 |
| ▸ | CA9 | Q16790 | 5/20 | 0.95 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.95 |
| ▸ | TSHR | P16473 | 1/20 | 0.95 |
| ▸ | CES2 | O00748 | 1/20 | 0.67 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,4-Dihydroxybenzoic Acid SCHEMBL28080 | 0.98 | CA12 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL28285004 | 0.98 | CA12 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL29573604 | 0.98 | CA12 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL8906720 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL8603122 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL8921001 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL8920707 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL1198473 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL3408180 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 | |
| 2,4-Dihydroxybenzoic Acid SCHEMBL8603120 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024082323-A1 | MIXED IRON ORE BENEFICIATION METHOD | 鞍钢集团北京研究院有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-115518766-A | Mineral separation method for mixed iron ore | 鞍钢集团北京研究院有限公司 | 2022-12-27 | — | — | CN | claimed |
| US-20210179975-A1 | COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX | SPECIALTY OPERATIONS FRANCE (FR) | 2021-06-17 | — | — | US | claimed |
| WO-2024082323-A1 | MIXED IRON ORE BENEFICIATION METHOD | 鞍钢集团北京研究院有限公司 | 2024-04-25 | — | — | WO | disclosed |
| US-11441105-B2 | Composition containing lanthanide metal complex | RHODIA OPERATIONS | 2022-09-13 | — | — | US | disclosed |
| CN-111479913-B | Compositions containing lanthanide metal complexes | 罗地亚经营管理公司 | 2021-12-21 | — | — | CN | disclosed |
| US-20210179975-A1 | COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX | SPECIALTY OPERATIONS FRANCE (FR) | 2021-06-17 | — | — | US | disclosed |
| CN-111479913-A | Compositions containing lanthanide metal complexes | 罗地亚经营管理公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-109301205-A | A kind of dedicated anti-inflatable lithium titanate anode material of lithium battery and preparation method | 成都新柯力化工科技有限公司 | 2019-02-01 | — | — | CN | disclosed |
| CN-105945277-B | Onion-like fullerene cladding Metal Palladium core-shell structure nanometer particle and preparation method thereof | 中国工程物理研究院激光聚变研究中心 | 2018-02-09 | — | — | CN | disclosed |
| US-6015792-A | Specific eatable taste modifiers | BIORESEARCH, INC. (US) | 2000-01-18 | — | — | US | disclosed |
| EP-0035770-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A GLYCOSIDIC ANTIBIOTIC AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | disclosed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | disclosed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | disclosed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | disclosed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | disclosed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | disclosed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | disclosed |